D21 Kategorie · weitere Spezifizierung erforderlich Other benign neoplasms of connective and other soft tissue
ICD-10-CM D21 identifies “Other benign neoplasms of connective and other soft tissue” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Kapitel 2: Neoplasms
Hinweise zum Code
Includes11
- benign neoplasm of blood vessel
- benign neoplasm of bursa
- benign neoplasm of cartilage
- benign neoplasm of fascia
- benign neoplasm of fat
- benign neoplasm of ligament, except uterine
- benign neoplasm of lymphatic channel
- benign neoplasm of muscle
- benign neoplasm of synovia
- benign neoplasm of tendon (sheath)
- benign stromal tumors
Excludes 113
- benign neoplasm of articular cartilage (D16.-)
- benign neoplasm of cartilage of larynx (D14.1)
- benign neoplasm of cartilage of nose (D14.0)
- benign neoplasm of connective tissue of breast (D24.-)
- benign neoplasm of peripheral nerves and autonomic nervous system (D36.1-)
- benign neoplasm of peritoneum (D20.1)
- benign neoplasm of retroperitoneum (D20.0)
- benign neoplasm of uterine ligament, any (D28.2)
- benign neoplasm of vascular tissue (D18.-)
- hemangioma (D18.0-)
- lipomatous neoplasm (D17.-)
- lymphangioma (D18.1)
- uterine leiomyoma (D25.-)
Hinweise übergeordneter Ebenen
Kapitel 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Spezifischere Codes
D21.0Benign neoplasm of connective and other soft tissue of head, face and neckAbrechenbarer, spezifischer CodeD21.1Benign neoplasm of connective and other soft tissue of upper limb, including shoulderKategorie · weitere Spezifizierung erforderlichD21.2Benign neoplasm of connective and other soft tissue of lower limb, including hipKategorie · weitere Spezifizierung erforderlichD21.3Benign neoplasm of connective and other soft tissue of thoraxAbrechenbarer, spezifischer CodeD21.4Benign neoplasm of connective and other soft tissue of abdomenAbrechenbarer, spezifischer CodeD21.5Benign neoplasm of connective and other soft tissue of pelvisAbrechenbarer, spezifischer CodeD21.6Benign neoplasm of connective and other soft tissue of trunk, unspecifiedAbrechenbarer, spezifischer CodeD21.9Benign neoplasm of connective and other soft tissue, unspecifiedAbrechenbarer, spezifischer CodeVerweise im offiziellen Index
Verweise anderer Codes (2)
Excludes 1 · benign neoplasm of synovia (D21.-)
Code first · neoplasm (C49.-, C79.89, D21.-, D48.1-)
Verlauf
Codeverlauf
Keine Änderung seit der ersten Erfassung
GeändertUnverändert
FY2016
Gültig ab
- Erstmals erfasst
Other benign neoplasms of connective and other soft tissue
Kategorie — spezifischeren Code auswählen
CDC/NCHS · FY2016Alle Ausgaben (19)
| Alle Ausgaben | Gültig ab | Codeverlauf |
|---|---|---|
| FY2016 | 2015-10-01 | Erstmals erfasst |
| FY2017 | 2016-10-01 | Keine tabellarische Änderung |
| FY2018 | 2017-10-01 | Keine tabellarische Änderung |
| FY2019 | 2018-10-01 | Keine tabellarische Änderung |
| FY2020 | 2019-10-01 | Keine tabellarische Änderung |
| FY2020 · April | 2020-04-01 | Keine tabellarische Änderung |
| FY2021 | 2020-10-01 | Keine tabellarische Änderung |
| FY2021 · 01-01 | 2021-01-01 | Keine tabellarische Änderung |
| FY2022 | 2021-10-01 | Keine tabellarische Änderung |
| FY2022 · 04-01 | 2022-04-01 | Keine tabellarische Änderung |
| FY2023 | 2022-10-01 | Keine tabellarische Änderung |
| FY2023 · 04-01 | 2023-04-01 | Keine tabellarische Änderung |
| FY2024 | 2023-10-01 | Keine tabellarische Änderung |
| FY2024 · 04-01 | 2024-04-01 | Keine tabellarische Änderung |
| FY2025 | 2024-10-01 | Keine tabellarische Änderung |
| FY2025 · 04-01 | 2025-04-01 | Keine tabellarische Änderung |
| FY2026 | 2025-10-01 | Keine tabellarische Änderung |
| FY2026 · April | 2026-04-01 | Keine tabellarische Änderung |
| FY2027 | 2026-10-01 | Keine tabellarische Änderung |
Entdecken Sie die spezifischeren Codes dieser Kategorie. Die Referenzprüfung bestätigt keine klinische Eignung und garantiert keine Erstattung.